Compared to the NC group, the shGALNT1 group had a much smaller mean tumor volume and tumor weight (Fig. 4A-C), manifesting that targeted knockdown of GALNT1 expression effectively inhibited tumor proliferation in vivo. This evidence concerns the gene GALNT1 and neoplasm.